Aurobindo Pharma’s arm gets OAI classification from USFDA for Rajasthan unit-II

18 Mar 2026 Evaluate

United States Food and Drug Administration (USFDA) has classified Aurobindo Pharma’s wholly owned subsidiary -- Eugia Pharma Specialities’ Unit-II situated at Rajasthan as a ‘Official Action Indicated’ (OAI) following an inspection conducted from November 03 to November 14, 2025. At the end of the inspection, a ‘Form 483’ was issued with 09 observations. 

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1289.00 41.05 (3.29%)
20-Mar-2026 13:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.25
Dr. Reddys Lab 1298.60
Cipla 1258.20
Zydus Lifesciences 892.75
Lupin 2320.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×